Kevin Boyle, Alaunos Therapeutics CEO
Ziopharm rebrands to Alaunos, closes Boston office with new CEO at the reins
A little over a year after facing an activist attack that saw former CEO Laurence Cooper survive but retire a few months later, Ziopharm Oncology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
